SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,285,000 | -88.8% | 19,600 | -89.2% | 0.00% | -90.0% |
Q1 2021 | $11,506,000 | -42.2% | 181,440 | +27.0% | 0.02% | -37.5% |
Q4 2020 | $19,901,000 | +13.6% | 142,822 | -2.4% | 0.03% | +6.7% |
Q3 2020 | $17,524,000 | +19.8% | 146,337 | +42.9% | 0.03% | +11.1% |
Q2 2020 | $14,623,000 | -31.3% | 102,430 | -52.9% | 0.03% | +28.6% |
Q1 2020 | $21,292,000 | +145.2% | 217,664 | +188.1% | 0.02% | +50.0% |
Q4 2019 | $8,685,000 | +118.4% | 75,551 | +31.3% | 0.01% | +100.0% |
Q3 2019 | $3,976,000 | – | 57,551 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |